A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PATZ1 | hg19_v2_chr22_-_31742218_31742350 | 0.96 | 2.1e-03 | Click! |
KLF4 | hg19_v2_chr9_-_110251836_110251927 | 0.54 | 2.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_220252603 Show fit | 7.23 |
ENST00000322176.7
ENST00000273075.4 |
aspartyl aminopeptidase |
|
chr2_+_74212073 Show fit | 6.80 |
ENST00000441217.1
|
AC073046.25 |
|
chrX_-_1331527 Show fit | 6.27 |
ENST00000381567.3
ENST00000381566.1 ENST00000400841.2 |
cytokine receptor-like factor 2 |
|
chr2_-_220252530 Show fit | 5.64 |
ENST00000521459.1
|
aspartyl aminopeptidase |
|
chr19_-_38878632 Show fit | 5.11 |
ENST00000586599.1
ENST00000334928.6 ENST00000587676.1 |
gametogenetin |
|
chr7_+_97910962 Show fit | 4.90 |
ENST00000539286.1
|
brain protein I3 |
|
chr2_+_20866424 Show fit | 4.63 |
ENST00000272224.3
|
growth differentiation factor 7 |
|
chr9_+_139971921 Show fit | 4.60 |
ENST00000409858.3
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
|
chr12_+_132379160 Show fit | 4.16 |
ENST00000321867.4
|
unc-51 like autophagy activating kinase 1 |
|
chr1_+_11333546 Show fit | 4.15 |
ENST00000376804.2
|
UbiA prenyltransferase domain containing 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 13.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.4 | 12.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 11.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 10.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.4 | 10.5 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 9.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.7 | 9.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 8.8 | GO:0006414 | translational elongation(GO:0006414) |
0.4 | 8.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 8.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 49.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 36.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 31.7 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 28.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 24.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 21.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 19.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 18.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 17.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 15.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 52.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 35.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 24.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 19.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 15.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 15.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 12.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 12.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 11.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 10.9 | GO:0017166 | vinculin binding(GO:0017166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 30.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 20.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 19.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 19.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 18.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 16.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 14.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 14.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.5 | 13.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 13.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 21.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 21.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 18.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 17.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 15.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 15.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 15.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 13.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 13.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 12.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |